Robert Andrade
Director of Finance/CFO at FENNEC PHARMACEUTICALS INC.
Net worth: 1 M $ as of 2024-03-30
Network origin in Robert Andrade first degree
Entity | Entity type | Industry | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 25 | |
Millennium Partners LLC
5
| Extinct | Miscellaneous Commercial Services | 5 |
DCML LLC
1
| Private Company | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Robert Andrade via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
UNIVERSAL HEALTH SERVICES, INC. | Hospital/Nursing Management | Director/Board Member | |
PTC THERAPEUTICS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
GENTIUM S.P.A. (ADR) | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal Director/Board Member | |
Micell Technologies, Inc.
Micell Technologies, Inc. Pharmaceuticals: MajorHealth Technology Micell Technologies, Inc. operates as a biomedical device company. It develops interventional cardiology systems for vascular drug delivery. The firm offers MiStent SES is designed to optimize healing in patients with coronary artery disease. The company was founded by Joseph M. DeSimone and James B. McClain in 1995 and is headquartered in Durham, NC. | Pharmaceuticals: Major | Director of Finance/CFO | |
Southpoint Capital Advisors LP
Southpoint Capital Advisors LP Investment ManagersFinance Southpoint Capital Advisors (Southpoint) is an independent, SEC-registered independent investment adviser and hedge fund manager headquartered in New York City. The firm was founded in 2004 by John Clark, II. Southpoint provides discretionary investment advice to private investment funds. | Investment Managers | Analyst-Equity | |
EUSA Pharma, Inc.
EUSA Pharma, Inc. Pharmaceuticals: MajorHealth Technology EUSA Pharma is a rapidly growing transatlantic specialty pharmaceutical company focused on in-licensing, developing and marketing late-stage oncology, pain control and critical care products. The company currently has eight products on the market, including Caphosol for the treatment of oral mucositis, a common and debilitating side-effect of radiation therapy and high-dose chemotherapy, ProstaScint for imaging the extent and spread of prostate cancer, Quadramet for the treatment of pain in patients whose cancer has spread to the bones, Erwinase and Kidrolase for the treatment of acute lymphoblastic leukemia and the antibiotic surgical implant Collatamp. EUSA also has several products in late-stage development, notably Collatamp topical, a gentamicin impregnated collagen sponge for the prevention and treatment of infected skin ulcers, and CollaRx bupivacaine implant for local post-surgical pain control. Founded in 2006, EUSA Pharma is supported by a consortium of leading life science capital investors, comprising TVM Capital, Essex Woodlands, 3i, Goldman Sachs, Advent Venture Partners, SV Life Sciences, NeoMed and NovaQuest. Since its foundation, the company has raised over $275 million, and completed several significant transactions, including the acquisitions of Cytogen Corporation, Talisker Pharma Ltd, the French biopharmaceutical company OPi SA and the European antibiotic and pain control business of Innocoll Pharmaceuticals Inc. As part of its rapid growth strategy the company has established commercial infrastructure in the US, a pan-European presence covering over 20 countries and a wider distribution network in a further 25 territories. EUSA Pharma plans to continue its aggressive program of acquisitions and in-licensing within its specialist areas of medical and geographic focus, in line with its ambitious target to create a rapidly growing $1 billion company by the beginning of the next decade. | Pharmaceuticals: Major | Sales & Marketing | |
McGill University Health Centre Foundation | Investment Trusts/Mutual Funds | Chief Executive Officer Director/Board Member | |
MOLMED S.P.A. | Pharmaceuticals: Major | Director/Board Member | |
GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
The Trustees of Columbia University in The City of New York | College/University | Doctorate Degree Undergraduate Degree | |
Duke University
Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Graduate Degree Masters Business Admin | |
University of Pennsylvania | College/University | Undergraduate Degree | |
VHS of Michigan, Inc.
VHS of Michigan, Inc. Hospital/Nursing ManagementHealth Services The Detroit Medical Center's (DMC) record of service has provided medical excellence throughout the history of the Metropolitan Detroit area. From the founding of Children's Hospital in 1886, to the creation of the first mechanical heart at Harper Hospital 50 years ago. Their medical experts are nationally recognized and each year, hundreds of DMC doctors are included in the list of America's Best Doctors. A reputation for excellence draws patients to world-class programs in oncology, organ transplant, cardiology, women's services, neurosciences, stroke treatment, optometry, orthopedics, pediatrics and rehabilitation. They are the leading academically integrated system in metropolitan Detroit and the largest health care provider in southeast Michigan. The DMC has more than 2,000 licensed beds and 3,000 affiliated physicians. Detroit Medical Center facilities employ best practices and conduct business in an atmosphere of respect and professionalism. Their recognition of and attention to diversity in their business operations and healthcare services is unparalleled. Their volunteer efforts in health education & disease prevention represent an ongoing commitment to the health and well-being of the communities they serve. The DMC continues to meet the health care needs of a growing community, offering the best in medical research & development, advanced technology and optimum clinical services. | Hospital/Nursing Management | President President | |
Organon NV
Organon NV Pharmaceuticals: MajorHealth Technology N.V. Organon engages in the development, manufacture, and sale of prescription medicines. It offers products for cardiovascular diseases, fertility, gynecology, anesthesia, respiratory, consumer health care, neuroscience as well as immunology, animal health, and oncology. Its products include mometasone furoate inhalation powder, moxifloxacin, pegylated liposomal doxorubicin HCI, desogestrel, desloratadine, sun care, flu medicine, foot care, follitropin beta, formoterol fumarate inhalation powder, hormone therapy, and canine vaccines. The company was founded in 1923 and is headquartered in Oss, the Netherlands. | Pharmaceuticals: Major | Corporate Officer/Principal | |
McGill University | College/University | Corporate Officer/Principal Masters Business Admin | |
Macquarie Capital (USA), Inc.
Macquarie Capital (USA), Inc. Investment Banks/BrokersFinance Founded in 2001, Macquarie Capital (USA), Inc. is a registered broker/dealer located in New York City. The firm is a subsidiary of Macquarie Bank Ltd. (ASX: MBL). They provide coverage of the following industries: resources, healthcare, security/defense, transportation, financial services, retail/consumer products, TMET (telecommunications, media, entertainment and technology), oil & gas, diversified manufacturing/distribution and infrastructure/utilities. Macquarie Capital (USA), Inc. is a member of FINRA. | Investment Banks/Brokers | Analyst-Equity | |
Yale University | College/University | Doctorate Degree | |
University of Ottawa | College/University | Corporate Officer/Principal Masters Business Admin | |
University of Toronto | College/University | Undergraduate Degree Graduate Degree | |
Javelin Pharmaceuticals, Inc.
Javelin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Javelin Pharmaceuticals, Inc. develops pharmaceutical drugs. It is a specialty pharmaceutical company that applies innovative proprietary technologies to develop new drugs and improved formulations of existing drugs that target current unmet and underserved medical market. The company's product candidates address the acute moderate-to-severe pain medication market segment. It has three late stage product candidates in development: Dyloject (diclofenac sodium, injectable), Rylomine (intranasal morphine) and PMI-150 (intranasal ketamine). The company was founded on February 23, 1998 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Founder Director/Board Member | |
University of Milan | College/University | Corporate Officer/Principal Doctorate Degree | |
University of Huddersfield | College/University | Undergraduate Degree | |
Meridian Credit Management LLC
Meridian Credit Management LLC Investment ManagersFinance Meridian Credit Management LLC, dba Gulf Stream Asset Management (GSM), is an independent, SEC-registered investment advisor and hedge fund manager headquartered in Charlotte, North Carolina. The firm was founded in 2002 as Gulf Stream Asset Management LLC. GSM manages a variety of collateralized loan obligations (CLOs) for institutional clients. | Investment Managers | Corporate Officer/Principal | |
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Biotechnology | Corporate Officer/Principal | |
McGill University Health Center
McGill University Health Center Hospital/Nursing ManagementHealth Services McGill University Health Center provides health care services. The firm offers multidisciplinary patient centric care services. The company was founded in 1997 and is headquartered in Montreal, Canada. | Hospital/Nursing Management | President Chairman | |
OxThera AB
OxThera AB Pharmaceuticals: GenericHealth Technology OxThera AB develops pharmaceutical products for treatment of hyperoxaluria. Its intellectual property includes worldwide patents for compositions and treatment of hyperoxaluria with bacteria and enzymes. The firm?s products in pipeline include Oxabact, for the treatment of primary hyperoxaluria and oxazyme for the prevention of oxalate malabsorption and recurring kidney stones in secondary hyperoxaluria. The company was founded in 2005 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Generic | Director/Board Member | |
Biogen Canada, Inc. | Corporate Officer/Principal | ||
Kurma Biofund FCPR
Kurma Biofund FCPR Investment ManagersFinance Kurma Biofund seeks investment opportunities in life science and biotechnology companies located in Europe. The investments are done in cooperation with medical institutes and universities such as Institut Pasteur and Institut Curie. Its investment size ranges between €0.10 and €6 million. | Investment Managers | Corporate Officer/Principal | |
Spector Consulting Services
Spector Consulting Services Miscellaneous Commercial ServicesCommercial Services Spector Consulting Services engages in the provision of pharmacology expertise. The company is headquartered in Durham, NC. | Miscellaneous Commercial Services | President | |
ARCH BIOPARTNERS INC. | Pharmaceuticals: Major | Director/Board Member | |
Biogen International GmbH
Biogen International GmbH Pharmaceuticals: MajorHealth Technology Biogen International GmbH produces pharmaceuticals. It develops medicines for psoriasis and multiple sclerosis. Its products include FUMADERM and BG-12. The company was founded in 1983 and is headquartered in Lucerne, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal | |
KAROLINSKA DEVELOPMENT AB | Financial Conglomerates | Director/Board Member | |
The University of North Carolina at Charlotte | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Sirius Healthcare Partners GmbH
Sirius Healthcare Partners GmbH Investment ManagersFinance Sirius Healthcare Partners GmbH provides independent advice to small and mid-cap healthcare companies, venture capital firms, institutional and private investors. The firm's services include strategic advisory, mergers and acquisition and financing advisory. It serves in the area of biotechnology, medical technology and diagnostics, platform technologies and healthcare markets. The company was founded by Subhasis Roy, Khalid Islam, Ernesto Mancosu, Werner Tschollar, Andreas Vogler and Mikael von Euw and is headquartered in Zurich, Switzerland. | Investment Managers | Founder | |
Gentium GmbH | Chief Operating Officer | ||
Minoryx Therapeutics SL
Minoryx Therapeutics SL BiotechnologyHealth Technology Minoryx Therapeutics SL engages in the development of drugs for the orphan genetic diseases of the central nervous system. The company was founded by Marc Martinell, Joan Aymami, Nigel Ten Fleming and Xavier Barril in 2011 and is headquartered in Barcelona, Spain. | Biotechnology | Chairman | |
Prev AbR LLC
Prev AbR LLC BiotechnologyHealth Technology Prev AbR LLC develops biologic and beta-lactamase compounds. The private company is based in Bethesda, MD. The company was founded by Khalid Islam. | Biotechnology | Founder | |
Point72 Asset Management LP
Point72 Asset Management LP Investment ManagersFinance Point72 Asset Management LP (Point72) is a SEC-registered investment advisor and hedge fund manager headquartered in Stamford, Connecticut. The firm was founded in 2014 and formerly known as Stamford Harbor Capital LP. They are a subsidiary of Point72 LP, which is owned by Point72 Capital Holdings LP. Point72 provides investment management services to the Point72 Funds. | Investment Managers | Portfolio Manager-Equities | |
PROCESSA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
PTC Therapeutics Ltd.
PTC Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Founded in 2012, PTC Therapeutics Ltd. is a British pharmaceutical company that develops pharmaceutical products. Part of PTC Therapeutics, Inc., the private company is based in London, UK. | Pharmaceuticals: Major | Director/Board Member | |
Life Sciences Management GmbH | Chief Executive Officer |
Statistics
International
United States | 27 |
Canada | 8 |
United Kingdom | 6 |
Switzerland | 5 |
Italy | 4 |
Sectoral
Health Technology | 20 |
Finance | 12 |
Consumer Services | 11 |
Health Services | 4 |
Commercial Services | 3 |
Operational
Director/Board Member | 86 |
Corporate Officer/Principal | 82 |
Chairman | 29 |
President | 28 |
Independent Dir/Board Member | 25 |
Most connected contacts
Insiders | |
---|---|
Khalid Islam | 29 |
Arthur T. Porter | 22 |
Marco Brughera | 19 |
Steven Skolsky | 17 |
Fred H. Mermelstein | 16 |
Adrian Haigh | 15 |
Claudio F. Bussandri | 15 |
Peter Morand | 12 |
William P. Peters | 11 |
Rostislav Raykov | 11 |
Alexander D. Smith | 10 |
Chris Rallis | 10 |
Donald William Kufe | 9 |
Jodi Cook | 9 |
James A. Klein | 8 |
- Stock Market
- Insiders
- Robert Andrade
- Company connections